The average selling price for REBEL in the Netherlands dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the REBEL device in the Netherlands can be viewed in GlobalData’s micro pricing report. Buy the report here.
The REBEL is sold by Boston Scientific in the Coronary Stents – BMS market. Bare metal stents (BMS) are uncoated stents that are permanently placed inside the artery. These stents are constructed from a range of metals, including nitinol, stainless steel, and cobalt chromium.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Boston Scientific’ Coronary Stents – BMS device pricing in the Netherlands, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.